Switzerland based Dietrich Engineering Consultants has announced the acquisition of UK based Biotech and pharmaceutical system provider, Extract Technology, from Wabash National Corp, a U.S. listed trailer manufacturing company. The acquisition included Extract Technology business in the U.K. and the U.S. The sale closed June 30, 2021, with Extract Technology continuing operations under the ownership […]
Switzerland-based global private markets firm, Partners Group, has, on behalf of its clients, agreed to acquire Pharmathen, a Greece-based pharmaceutical company, from international U.S. based investment firm BC Partners. The transaction values Pharmathen at
Ermenegildo Zegna Group, the privately-held Italian fashion company, will go public on the New York Stock Exchange later this year by way of a merger with Investindustrial Acquisition Corp., a special purpose acquisition corporation – or
Kuros Biosciences, a bone graft technologies company, has entered into a royalty purchase agreement with Xoma Corporation, under which Xoma has purchased a proportion of the potential future pre-commercial milestone payments and all the potential
HEB Swiss Investment, a Zurich-based holding company owned by a German private investor, has entered into an agreement to sell its major stake (29.3 %) in listed Cicor Technologies (SIX Swiss Exchange: CICN) to One Equity Partners.
Homburger acted as legal counsel to Nets A/S in relation to the merger of its two Swiss subsidiaries Concardis Schweiz and CCV (Switzerland). The Homburger team was led by partner Daniel Daeniker (corporate / m&
Bär & Karrer acts as legal counsel to Union Bancaire Privée (UBP) in the agreement it entered into with Banco Comercial Português (BCP), whereby UBP will acquire all the shares of the
The Japanese group Mabuchi Motor Co. acquired Swiss-based Electromag from a private shareholder. The acquisition of Electromag will allow Mabuchi to expand its sales to the medical market and increase its expertise in brushless motors.
Illumiti Group, the SAP systems integration and management consultancies in North America, was acquired by Syntax Systems, a multi-cloud and multi-ERP managed cloud provider for mission-critical applications and a portfolio company of Novacap, a Montreal-based
Novartis has signed a collaboration agreement and option to acquire Cellerys, a Zurich-based start-up that is researching a therapy to combat multiple sclerosis (MS). This therapy has the potential to delay the progression of the
